Non-invasive Brain Stimulation to Improve Unsteady Gait in Older Adults (StimGait)
NCT ID: NCT06008431
Last Updated: 2026-01-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
27 participants
INTERVENTIONAL
2024-06-03
2025-11-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Personalized tDCS in Elderly Fallers Study
NCT03814304
The Brain Stimulation and Physical Therapy Study
NCT04181658
Optimizing tDCS to Improve Dual Task Gait and Balance
NCT04295798
Feasibility of Home-based tES for Older Adults at Risk of Falling
NCT04732533
Testing Effectiveness of a Stochastic Noise Stimulator to Immediately Improve Balance and Gait
NCT06688578
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
tDCS intervention
Ten, once-daily, 20-min sessions of tDCS will be provided over two consecutive weeks.
Transcranial direct current stimulation (tDCS) (active)
The tDCS montage is developed to modulate the functional connectivity between the dorsal attention network and the default network.
Sham and then tDCS
Five, once-daily, 20-min sessions of sham in week one followed by five, once-daily, 20-min sessions of tDCS in week two.
Transcranial direct current stimulation (tDCS) (active)
The tDCS montage is developed to modulate the functional connectivity between the dorsal attention network and the default network.
Transcranial direct current stimulation (tDCS) (Sham)
The tDCS "Acti-" Sham montage is developed to recreate the cutaneous sensations associated with tDCS, yet essentially a null electrical field over the networks of interest.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transcranial direct current stimulation (tDCS) (active)
The tDCS montage is developed to modulate the functional connectivity between the dorsal attention network and the default network.
Transcranial direct current stimulation (tDCS) (Sham)
The tDCS "Acti-" Sham montage is developed to recreate the cutaneous sensations associated with tDCS, yet essentially a null electrical field over the networks of interest.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ability to speak and read English.
* Ability to walk independently and continuously for at least 1 minute.
* Elevated gait variability as defined by a coefficient of variation (CoV) about average stride time larger and equal to 0.025 during straight-line walking at preferred speed.
Exclusion Criteria
* Parkinson's disease, multiple sclerosis, stroke, active brain tumor, or other neurological disorders.
* Self-reported pain or lower extremity deformity that significantly disrupts walking.
* Contraindications to MRI or tDCS.
* An episode of acute illness or exacerbation of a diagnosis that requires hospitalization or active treatment within the past 3 months.
* Current treatment for congestive heart failure, angina, uncontrolled arrythmia, deep vein thrombosis, or other uncontrolled cardiovascular events.
* Myocardial infarction, coronary artery bypass grafting, angioplasty, or other cardiac conditions within the past 3 months,
* Active cancer for which chemo/radiation therapy is being received.
* Psychiatric co-morbidity including major depressive disorder, schizophrenia, psychosis, or other psychiatric illness.
* Recent use of any sedating medications (sedatives, anti-psychotics, hypnotics, anti-depressants) or change in medication within the previous month.
* Chronic vertigo or other diagnosed vestibular disorders.
* Legal blindness, visual impairments that cannot be corrected with glasses, contact lenses, medicine, or surgery.
* Those without WiFi access
* Those who do not plan to live in their current homes for the duration of the study
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Aging (NIA)
NIH
Hebrew SeniorLife
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
On-Yee Lo, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00057363
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.